Literature DB >> 12705632

Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing.

Yanping Chen1, Susan R Rittling.   

Abstract

We have developed a series of novel mammary epithelial cell lines from tumors arising in strain 129 mice, with the ultimate goal of evaluating the role of host factors in the development of bone metastases. Mammary tumors were induced in mice with subcutaneously implanted medroxyprogesterone acetate (MPA) pellets followed by administration of DMBA by oral gavage. Mammary tumor development was efficient in the 129 strain and was independent of osteopontin (OPN) expression. Epithelial cell lines were isolated from these tumors; surprisingly, these cells did not form tumors upon inoculation into the mammary fat pad of syngeneic mice, even when MPA was present. One OPN-deficient cell line was selected for further study; full transformation of these cells required expression of both polyoma middle T and activated ras. These doubly transfected cells, 1029 GP+Er3, grew in soft agar, and formed hormone-independent tumors efficiently in the mammary fat pad that spontaneously metastasized to several soft tissue sites but not to the bone. Derivatives of these cells were isolated from tumors arising in the fat pad and from a lung metastasis (r3T and r3L, respectively): these cells formed tumors more rapidly in the fat pad than the parental GP+Er3 cells. Upon left ventricle injection, the r3T and r3L cells formed osteolytic bone metastases in 129 mice, with few metastases seen in other organs. These tumors filled the marrow cavity, and caused extensive destruction of both cortical and trabecular bone. Intriguingly, in an alternative syngeneic host, (129xC57B1/6) F1, osteolytic bone metastases were not seen on x-ray; instead extensive liver metastasis was present in these mice, indicating that genetic factors in these two strains regulate tumor cell homing and distribution during metastasis. These cell lines provide an important new tool in the study of bone metastasis, particularly in elucidating the role of host factors in the development of these lesions, as the 129 mouse strain is frequently used for genetic manipulations in the mouse.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705632     DOI: 10.1023/a:1022675031185

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  54 in total

1.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density.

Authors:  T Le Voyer; J Rouse; Z Lu; T Lifsted; M Williams; K W Hunter
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

Review 3.  Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

Authors:  T Yoneda; T Michigami; B Yi; P J Williams; M Niewolna; T Hiraga
Journal:  Cancer Treat Rev       Date:  1999-10       Impact factor: 12.111

4.  Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids.

Authors:  G S Smith; R L Walford; M R Mickey
Journal:  J Natl Cancer Inst       Date:  1973-05       Impact factor: 13.506

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Authors:  T Yoneda; A Sasaki; C Dunstan; P J Williams; F Bauss; Y A De Clerck; G R Mundy
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Regulation of activation-induced receptor activator of NF-kappaB ligand (RANKL) expression in T cells.

Authors:  Ruoxiang Wang; Liying Zhang; Xiaoren Zhang; Jose Moreno; Christina Celluzzi; Mehrdad Tondravi; Yufang Shi
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

Review 8.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

9.  Detection of mouse osteopontin by western blotting.

Authors:  S R Rittling; F Feng
Journal:  Biochem Biophys Res Commun       Date:  1998-09-18       Impact factor: 3.575

10.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

Authors:  M MacPhee; K P Chepenik; R A Liddell; K K Nelson; L D Siracusa; A M Buchberg
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

View more
  13 in total

1.  Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.

Authors:  Tajneen Natasha; Misty Kuhn; Owen Kelly; Susan R Rittling
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

Authors:  Bradley Yates; Craig Zetterberg; Vaishali Rajeev; Michael Reiss; Susan R Rittling
Journal:  Exp Cell Res       Date:  2007-08-01       Impact factor: 3.905

3.  Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation.

Authors:  Kader Yagiz; Susan R Rittling
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

4.  Myeloid-Derived Lymphatic Endothelial Cell Progenitors Significantly Contribute to Lymphatic Metastasis in Clinical Breast Cancer.

Authors:  Lisa Volk-Draper; Radhika Patel; Nihit Bhattarai; Jie Yang; Andrew Wilber; David DeNardo; Sophia Ran
Journal:  Am J Pathol       Date:  2019-08-15       Impact factor: 4.307

5.  Modulation of infection-mediated migration of neutrophils and CXCR2 trafficking by osteopontin.

Authors:  Rani Singh; Tommy Hui; Aritsune Matsui; Ziyad Allahem; Christopher D Johnston; Montserrat Ruiz-Torruella; Susan R Rittling
Journal:  Immunology       Date:  2016-10-07       Impact factor: 7.397

6.  Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.

Authors:  Anandi Sawant; Jonathan A Hensel; Diptiman Chanda; Brittney A Harris; Gene P Siegal; Akhil Maheshwari; Selvarangan Ponnazhagan
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

7.  A mouse model of breast cancer metastasis to the choroid of the eye.

Authors:  Misty Kuhn; Sarah Shah; Tajneen Natasha; Susan R Rittling
Journal:  Clin Exp Metastasis       Date:  2006-05-18       Impact factor: 5.150

8.  Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.

Authors:  Kerry A Whalen; Georg F Weber; Thomas L Benjamin; Brian S Schaffhausen
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

9.  Protective role of osteopontin in endodontic infection.

Authors:  Susan R Rittling; Craig Zetterberg; Kader Yagiz; Stephen Skinner; Noriyuki Suzuki; Akira Fujimura; Hajime Sasaki
Journal:  Immunology       Date:  2009-09-11       Impact factor: 7.397

Review 10.  Metastasis: recent discoveries and novel treatment strategies.

Authors:  Suzanne A Eccles; Danny R Welch
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.